Iron status and the treatment of the anemia of prematurity
- PMID: 12168242
- DOI: 10.1016/s0095-5108(02)00002-7
Iron status and the treatment of the anemia of prematurity
Abstract
Many unanswered issues regarding rhEPO therapy in prematurity remain, including which premature infants best respond to rhEPO, what the long-term effect of decreased erythrocyte transfusions is, how nutritional supplementation optimizes the effect of rhEPO, whether or not rhEpo therapy causes iron deficiency later in life, and whether or not it is safe to supplement with parenteral iron. Further study of rhEPO therapy and iron status in prematurity is necessary.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical